Di Lernia V & Peccerillo F. (2024). Long-Standing Remission After Tildrakizumab Treatment in a Case of Refractory Type I Pityriasis Rubra Pilaris in a Breast Cancer Patient. Dove Medical Press.
Chicago Style (17th ed.) CitationDi Lernia V and Peccerillo F. Long-Standing Remission After Tildrakizumab Treatment in a Case of Refractory Type I Pityriasis Rubra Pilaris in a Breast Cancer Patient. Dove Medical Press, 2024.
MLA (9th ed.) CitationDi Lernia V and Peccerillo F. Long-Standing Remission After Tildrakizumab Treatment in a Case of Refractory Type I Pityriasis Rubra Pilaris in a Breast Cancer Patient. Dove Medical Press, 2024.
Warning: These citations may not always be 100% accurate.